Home > Updates > Research and Industry News > Industry News: MeiraGTx Ltd Announces Fast Track designation of gene therapy candidate for X-linked retinitis pigmentosa (XLRP)

Industry News: MeiraGTx Ltd Announces Fast Track designation of gene therapy candidate for X-linked retinitis pigmentosa (XLRP)

Newsletter Signup

To keep up to date with our news and activities,
please leave your details below

GDPR Compliance Please indicate your consent for Retina International to contact you via the email address listed for the purposes of general alerts and newsletters.